BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 17, 2012
View Archived Issues
Investigators discover two novel genes related to ALS
Read More
Amgen presents novel series of beta-secretase inhibitors
Read More
GeoVax presents promising phase II results for their HIV vaccines
Read More
Actelion designs novel orexin receptor antagonists
Read More
Research at Actelion yields new P2X7 receptor antagonists
Read More
Vertex Pharmaceuticals patents Na(V) channel inhibitors
Read More
University of Pittsburg presents new radioprotectants
Read More
Cystic Fibrosis Foundation Therapeutics and Pulmatrix enter collaboration
Read More
Novel PDE10A inhibitors created at Allergan
Read More
Georgetown University presents new AGBL2 inhibitors
Read More
Biodel advances with phase II insulin study
Read More
Novo-23 presented as novel antitubercular drug candidate with a new antibiotic target
Read More
RQ-00201894 selected for preclinical evaluation
Read More
DMC recommends Celsion's HEAT Study continuation
Read More
Phase III study of Japanese cedar pollinosis immunotherapy meets primary endpoint
Read More
Boehringer Ingelheim begins expanded access program for afatinib
Read More
Cornerstone Therapeutics provides regulatory update on lixivaptan
Read More
Dara BioSciences acquires exclusive U.S. right to Gelclair
Read More
Oncodesign and Sanofi enter kinase research collaboration
Read More
Treanda now available in Canada
Read More
Pearl Therapeutics identifies optimal dose of COPD treatment candidate
Read More
RepliGen withdraws MAA for SecreFlo
Read More
Investigator-sponsored stem cell study for peripheral artery disease approved in Japan
Read More
Janssen begins dosing in phase II antidepressant study
Read More